The Cardinals traded for Khalil Greene yesterday, but perhaps the most significant event of the day for them was Chris Carpenter's nerve conduction test to determine how effective his November surgery to move the problematic ulnar nerve in his pitching elbow. The nerve problem was what ended his 2008 season early and at the time that his season was shut down, there was some speculation that it could be a career-ending problem (he's struggled with the nerve before, first around 2003 and 2004). Carpenter's future is probably riding on the result of this test, but he seems positive. He talked with BP's David Laurila last weekend and seemed optimistic about pitching next year, calling the nerve transposition a "little, simple surgery." The Cardinals themselves are cautiously optimistic enough to wait on the result's from yesterday's test before they decide how to rebuild their rotation this winter.
It would really be a huge boost to the Cards to have Carpenter healthy next year. As it stands, their rotation could certainly use some help. If they have a healthy Chris Carpenter next year, they could use considerably less help and will probably focus on other needs. Then again, even if he gets a positive result from this nerve test, relying a lot on a guy with just over 20 innings since 2006 seems risky.




